カテゴリ： MarketLine, ドイツ, 企業調査

Bertelsmann SE & Co. KGaA：企業の戦略・SWOT・財務情報

◆英語タイトル：Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1669
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：50
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：メディア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Bertelsmann SE & Co. KGaA – Strategy, SWOT and Corporate Finance Report
Summary

Bertelsmann SE & Co. KGaA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bertelsmann SE & Co. KGaA (Bertelsmann or “the company”) is a media, services and education company engaged in television broadcasting, book publishing, magazine publishing services and printing businesses. It also offers business process outsourcing services, including customer services, data management, supply chain management, digital distribution, customer relations services, financial services, customized and professional IT services. The company primarily operates in Germany, France, the UK, Spain and the US. Bertelsmann is headquartered in Gutersloh, Germany.

Scope

- Detailed information on Bertelsmann SE & Co. KGaA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bertelsmann SE & Co. KGaA in the form of a SWOT analysis
- An in-depth view of the business model of Bertelsmann SE & Co. KGaA including a breakdown and examination of key business segments
- Intelligence on Bertelsmann SE & Co. KGaA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bertelsmann SE & Co. KGaA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bertelsmann SE & Co. KGaA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bertelsmann SE & Co. KGaA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bertelsmann SE & Co. KGaA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Bertelsmann SE & Co. KGaA: Company Overview 9
Bertelsmann SE & Co. KGaA: Overview and Key Facts 9
Bertelsmann SE & Co. KGaA: Overview 9
Bertelsmann SE & Co. KGaA: Key Facts 9
Bertelsmann SE & Co. KGaA: Key Employees 10
Bertelsmann SE & Co. KGaA: Key Employee Biographies 12
Bertelsmann SE & Co. KGaA: Major Products and Services 17
Bertelsmann SE & Co. KGaA: Company History 18
Bertelsmann SE & Co. KGaA: Management Statement 24
Bertelsmann SE & Co. KGaA: Locations and Subsidiaries 26
Bertelsmann SE & Co. KGaA: Key Competitors 27
Bertelsmann SE & Co. KGaA: Company Analysis 28
Bertelsmann SE & Co. KGaA: Business Description 28
Bertelsmann SE & Co. KGaA: SWOT Analysis 30
Bertelsmann SE & Co. KGaA: SWOT Overview 30
Bertelsmann SE & Co. KGaA: Strengths 30
Bertelsmann SE & Co. KGaA: Weaknesses 31
Bertelsmann SE & Co. KGaA: Opportunities 31
Bertelsmann SE & Co. KGaA: Threats 32
Bertelsmann SE & Co. KGaA: Corporate Financial Deals Activity 33
Bertelsmann SE & Co. KGaA: Financial Deals Overview 33
Bertelsmann SE & Co. KGaA: Targets and Partners 34
Bertelsmann SE & Co. KGaA: Top Deals 2014 – 2018YTD* 35
Bertelsmann SE & Co. KGaA: Advisors 36
Bertelsmann SE & Co. KGaA: Top Legal Advisors 36
Bertelsmann SE & Co. KGaA: Top Financial Advisors 36
Bertelsmann SE & Co. KGaA: Mergers and Acquisitions 37
Bertelsmann SE & Co. KGaA: Corporate Venturing 38
Bertelsmann SE & Co. KGaA: Capital Raising 39
Bertelsmann SE & Co. KGaA: Divestments 40
Bertelsmann SE & Co. KGaA: Recent Developments 41
Bertelsmann SE & Co. KGaA: News and Events Summary 41
Bertelsmann SE & Co. KGaA: Business Expansion 44
Bertelsmann SE & Co. KGaA: Corporate Governance 45
Bertelsmann SE & Co. KGaA: Financial Deals 45
Bertelsmann SE & Co. KGaA: Financial Performance 46
Bertelsmann SE & Co. KGaA: Strategy and Operations 47
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: Bertelsmann SE & Co. KGaA: Key Facts
Table 2: Bertelsmann SE & Co. KGaA: Key Employees
Table 3: Bertelsmann SE & Co. KGaA: Locations and Subsidiaries
Table 4: Bertelsmann SE & Co. KGaA: Key Competitors
Table 5: Bertelsmann SE & Co. KGaA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Bertelsmann SE & Co. KGaA: M&A Average Deal Size - Value (US$m)
Table 7: Bertelsmann SE & Co. KGaA: Targets and Partners
Table 8: Bertelsmann SE & Co. KGaA: Top Deals 2014 - 2018YTD*
Table 9: Bertelsmann SE & Co. KGaA: Legal Advisor Ranking by Value (US$m)
Table 10: Bertelsmann SE & Co. KGaA: Financial Advisor Ranking by Value (US$m)
Table 11: Bertelsmann SE & Co. KGaA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Bertelsmann SE & Co. KGaA: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Bertelsmann SE & Co. KGaA: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 14: Bertelsmann SE & Co. KGaA: Corporate Venturing by Geography (2014 - YTD*2018)
Table 15: Bertelsmann SE & Co. KGaA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 16: Bertelsmann SE & Co. KGaA: Capital Raising by Deal Type (2014 - YTD*2018)
Table 17: Bertelsmann SE & Co. KGaA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 18: Bertelsmann SE & Co. KGaA: Divestments by Geography (2014 - YTD*2018)
Table 19: Bertelsmann SE & Co. KGaA: News and Events Summary
Table 20: Bertelsmann SE & Co. KGaA: Business Expansion
Table 21: Bertelsmann SE & Co. KGaA: Corporate Governance
Table 22: Bertelsmann SE & Co. KGaA: Financial Deals
Table 23: Bertelsmann SE & Co. KGaA: Financial Performance
Table 24: Bertelsmann SE & Co. KGaA: Strategy and Operations

List of Figures
Figure 1: Bertelsmann SE & Co. KGaA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Bertelsmann SE & Co. KGaA: M&A Average Deal Size - Value (US$m)
Figure 3: Bertelsmann SE & Co. KGaA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Bertelsmann SE & Co. KGaA: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Bertelsmann SE & Co. KGaA: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 6: Bertelsmann SE & Co. KGaA: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 7: Bertelsmann SE & Co. KGaA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Bertelsmann SE & Co. KGaA: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 9: Bertelsmann SE & Co. KGaA: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Bertelsmann SE & Co. KGaA: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Bertelsmann SE & Co. KGaA：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • HRG Group, Inc. (HRG)-石油・ガス分野：企業M&A・提携分析
    Summary HRG Group, Inc. (HRG), formerly, Harbinger Group Inc., is a diversified investment holding company, with interests in various businesses such as branded consumer products, which include consumer batteries, residential locksets, faucets, shaving and grooming products, personal care products, …
  • Intuitive Surgical Inc (ISRG)：企業の財務・戦略的SWOT分析
    Intuitive Surgical Inc (ISRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Teijin Ltd (3401)：医療機器：M&Aディール及び事業提携情報
    Summary Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, poly …
  • Maxar Technologies Ltd (MAXR)：企業の財務・戦略的SWOT分析
    Maxar Technologies Ltd (MAXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Otsuka Medical Devices Co Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Otsuka Medical Devices Co Ltd (Otsuka Medical Devices), a subsidiary of Otsuka Holdings Co Ltd, is a medical device manufacturing company. The company concentrates on revolutionary diagnostic and treatment technologies that find solutions in treating drug-refractory patients and intractable …
  • Mitsui & Co Ltd (8031)：石油・ガス：M&Aディール及び事業提携情報
    Summary Mitsui & Co Ltd (Mitsui) is a business conglomerate. The company sells, distributes, purchases, markets and supplies wide variety of products in business areas including iron and steel; non-ferrous metals; machinery; electronics; chemicals; energy-related commodities; foods & retail, lifesty …
  • Samruk-Energy：企業の戦略的SWOT分析
    Samruk-Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Cidara Therapeutics Inc (CDTX)：企業の財務・戦略的SWOT分析
    Summary Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include novel echinocandin CD101 IV, for the treatment of systemic candida in …
  • Orphazyme AS (ORPHA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Orphazyme A/S (Orphazyme) formerly Orphazyme ApS, is a biopharmaceutical company that develops heat shock protein based therapies for the treatment of orphan protein-misfolding diseases. Its lead product drug candidate arimoclomol is under clinical development for treating neuromuscular dise …
  • Concept Life Sciences Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Concept Life Sciences Ltd (Concept Life Sciences), formerly Peakdale Molecular Ltd, a subsidiary of Concept Life Sciences Holdings Ltd is a provider of integrated discovery and development solution. The company services include integrated drug discovery and development services and analytica …
  • Guardant Health Inc：医療機器：M&Aディール及び事業提携情報
    Summary Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection …
  • Patrys Ltd (PAB)：企業の財務・戦略的SWOT分析
    Summary Patrys Ltd (Patrys) is a therapeutic antibody development company focused on IgM antibodies and IgG antibody fragments in the field of oncology. The company's pipeline products include PAT-SC an immunoglobulin M type antibody used for the treatment of gastric cancer PAT-SM is a fully human m …
  • Oil States International, Inc.：企業の戦略・SWOT・財務分析
    Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Celldex Therapeutics Inc (CLDX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Celldex Therapeutics Inc (Celldex) is a bio-pharmaceutical company that discovers, develops and commercializes targeted immunotherapy technologies and cancer-targeting biologicsfor the treatment of various types of cancers. The company’s developmental pipeline comprises therapeutic antibodie …
  • Movenpick Schweiz AG：企業の戦略・SWOT・財務情報
    Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report Summary Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Allied Irish Banks, Plc：企業のM&A・事業提携・投資動向
    Allied Irish Banks, Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allied Irish Banks, Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Skyworks Solutions Inc (SWKS)：企業の財務・戦略的SWOT分析
    Skyworks Solutions Inc (SWKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Xped Limited (XPE)-エネルギー分野：企業M&A・提携分析
    Summary Xped Limited (Xped) formerly Raya Group Limited, is an Internet of Things company that develops software and hardware solutions. It offers auto discovery remote control, Xerts, and Xped app software; and hardware such as Xped ADRC Shields, Umbo-Xped ADRC Hub, UltraPlug, VariPlug, IRBlaster. …
  • Yuhan Corp (000100)：製薬・医療：M&Aディール及び事業提携情報
    Summary Yuhan Corp (Yuhan) researches, develops, manufactures and markets pharmaceutical products. The company offers API's and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, beta-lactase inhibitors, PEGlyated compounds and anti-histamines. …
  • Debiotech SA：医療機器：M&Aディール及び事業提携情報
    Summary Debiotech SA (Debiotech) is a medical device company that develops therapeutic devices and diagnostic products. The company’s products include patch-pump, injection, multi-fluidic cassette type system, infusion pump and microsystems. It develops products in the areas of implantable and exter …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆